Range Capital Acquisition Corp II (RNGT) Company Overview

What does Range Capital Acquisition Corp II do?

Range Capital Acquisition Corp II is a Cayman Islands exempted company created to find and complete a merger, share exchange, asset acquisition, reorganization, or similar transaction with one or more businesses. It is a special purpose acquisition company, or SPAC, rather than an operating enterprise. The March 31, 2026 Form 10-Q states that the company had not commenced operations, had not selected a specific target, and had not engaged in substantive target discussions as of the reporting date.

Which securities trade, and what does each represent?

The Nasdaq capital structure has three instruments. RNGTU units contain one Class A share and one-half warrant; RNGT is the separate Class A share; and RNGTW is the separate warrant. Each whole warrant is exercisable for one Class A share at $11.50 under the prospectus terms. Separate trading began November 24, 2025, as documented in the company’s November 2025 Form 8-K.

What kind of company could RNGT acquire?

The mandate is legally broad, but the latest annual filing says management expects to focus on biotechnology, healthcare, and technology. These sectors often combine large capital needs, specialized diligence, uncertain timelines, and wide valuation dispersion. RNGT’s present task is to convert trust capital, sponsor expertise, and public-market access into ownership of a future operating company.

How does RNGT make money before a merger?

A pre-combination SPAC has no conventional revenue model. RNGT does not yet earn product sales, subscriptions, fees, or operating margins. Its reported income comes primarily from interest earned on the IPO proceeds held in the trust account. That distinction is essential: pre-deal net income is largely a function of trust balance and short-term interest rates, not evidence of an operating franchise.

Where did the initial capital come from?

The IPO closed October 6, 2025 with $230.0 million of gross public proceeds, including the 3.0 million-unit over-allotment. A concurrent private placement sold 660,000 units for $6.6 million: 430,000 to the sponsor and 230,000 to BTIG. The official IPO closing announcement provides the offering-level context, while the final prospectus explains the security terms and sponsor economics.

What happens economically after a transaction?

After a business combination, the acquired company’s economics replace RNGT’s pre-deal profile. Cash surviving redemptions could fund consideration, debt repayment, working capital, or expansion. Revenue growth, margins, leverage, and free cash flow would then become the core drivers. Before a target is announced, operating forecasts remain speculative because the industry, valuation, and financing terms are unknown.

What does the latest quarter show?

How should the income statement be interpreted?

For the three months ended March 31, 2026, RNGT reported $2.059 million of interest from trust investments, $8,267 of bank investment income, and $223,542 of general and administrative costs. The result was $1.844 million of net income, or $0.06 per redeemable and non-redeemable ordinary share. The earnings are not comparable with normal operating profit: trust interest supports the redemption pool while the search organization consumes outside cash.

What changed on the balance sheet?

Trust securities increased from $232.105 million at December 31, 2025 to $234.164 million at March 31, 2026, exactly matching the quarter’s trust interest. Approximate redemption value rose from $10.09 to $10.18 per public share. Outside the trust, cash declined from $1.123 million to $922,610 as operating expenses were paid. Current assets were $1.062 million and current liabilities were $136,902, leaving reported working capital of $924,689.

The trust account, redemption value, and SPAC economics

RNGT’s largest asset is restricted rather than ordinary corporate cash. At March 31, 2026, the $234.164 million trust balance represented 99.53% of total assets, and the same amount was recorded as Class A shares subject to possible redemption. Public investors generally may redeem for pro rata trust value around a deal, extension vote, or liquidation, subject to the governing terms and claims.

How much of the capital is truly available for a deal?

Gross trust value is only the starting point. Redemptions can remove cash, the $8.05 million deferred underwriting fee is transaction-linked, and closing expenses can be material. A larger target or high redemptions could require PIPE equity, debt, backstops, or other financing. Effective acquisition currency is the combination of remaining trust cash, shares, warrants, and new capital.

What dilution is embedded before a target is chosen?

The structure includes 7.667 million Class B founder shares, 660,000 private-placement Class A shares, and 11.830 million outstanding warrants as of March 31, 2026. Founder shares were issued for $25,000 while public investors paid $10.00 per unit. This asymmetry creates an incentive conflict because the sponsor can benefit from a completed transaction even when public holders prefer redemption. Warrant exercise at $11.50 could further increase the post-deal share count.

What strategic history shaped RNGT?

RNGT’s short history is a sequence of capital-formation and governance events, not products and market share. The 2025 Form 10-K also connects the vehicle to management’s investment background and to Range Capital Acquisition Corp, the related first SPAC formed in 2024.

1. May 22, 2025
   RNGT was incorporated in the Cayman Islands, creating the legal shell that would raise capital and seek a business combination.
2. June 30, 2025
   The sponsor acquired 7,666,667 founder shares for $25,000, establishing the promote and pre-deal control structure.
3. September 30, 2025
   The registration statement became effective, enabling the public offering and fixing the initial security terms.
4. October 6, 2025
   The IPO closed with $230.0 million of public proceeds and a $6.6 million private placement; $230.0 million entered the trust.
5. November 24, 2025
   Class A shares and warrants became separately tradable as RNGT and RNGTW, allowing investors to separate redemption exposure from warrant optionality.
6. December 31, 2025
   The first year-end balance sheet showed $232.1 million in trust and $1.123 million of outside cash, setting the baseline for search-period liquidity.
7. March 31, 2026
   Trust value reached $234.2 million while outside cash fell to $0.923 million; the filing still reported no selected target or substantive target discussions.

Why does the related Range I vehicle matter?

Tim Rotolo formed Range I in July 2024; it completed a $115 million IPO that December. RNGT shares its chief executive and independent directors with that vehicle. The overlap supplies repeat-process experience but creates opportunity-allocation and time-commitment questions. The annual report says RNGT may pursue businesses previously discussed by Range I’s management, making the relationship both an asset and a conflict to monitor.

What gives RNGT an edge in the acquisition market?

RNGT’s potential advantage is human and transactional, not operational. Management describes a value-oriented search for underpriced assets in capital-constrained markets, with expected emphasis on biotechnology, healthcare, and technology. Broad discretion widens the opportunity set but makes pre-announcement diligence harder because investors cannot evaluate a fixed industry strategy.

Who are the real competitors?

RNGT competes with SPACs, private-equity sponsors, growth investors, strategic buyers, and traditional IPO routes. Targets compare valuation, funding certainty, sponsor reputation, governance, speed, and post-deal support. A $234 million trust is meaningful, but larger sponsors may offer deeper operating teams or committed capital; strategic buyers may pay for synergies; and a traditional IPO can avoid sponsor-promote dilution.

How durable is the stated advantage?

The scorecard is an analytical classification based on disclosed trust size, target flexibility, lack of current operations, and transaction uncertainty; it is not a credit rating or investment recommendation.

Who owns RNGT and who controls the vote?

Ownership has two layers: public Class A economics and founder Class B governance. At March 31, 2026, RNGT had 23.0 million redeemable public Class A shares, 660,000 non-redeemable Class A shares, and 7.667 million Class B founder shares. Class B holders also have pre-combination rights to appoint and remove directors before or in connection with the initial transaction.

Which holders have the largest disclosed positions?

How much voting leverage does the sponsor have?

Under one annual-report scenario in which all outstanding shares vote, 7,336,667 public shares—31.9% of IPO public shares—would also need to support an ordinary-resolution business combination. Under the filing’s one-third-quorum scenario, insider-held founder and private shares could be sufficient without additional public votes. These are not predictions; they show why quorum, redemptions, and sponsor voting agreements matter.

How strong is RNGT’s financial position?

Financial strength depends on the capital pool. The trust grew during Q1 2026 but is restricted for redemption or a transaction. At March 31, 2026, RNGT had $922,610 of outside cash, $924,689 of working capital, and no working-capital loans. Management nevertheless reported substantial doubt about one-year going-concern capacity because outside-trust funds may not cover the cost of finding and negotiating a deal.

Why do profit and cash flow tell different stories?

Q1 net income was positive, yet operating cash flow was negative $199,998 because trust interest stayed inside the trust and increased the redemption liability. RNGT also pays a $20,000 monthly support fee; $60,000 was paid in Q1 2026. Researchers should separate protected trust growth, which supports redemption value, from unrestricted cash burn, which may eventually require sponsor loans.

What risks and opportunities could change the outcome?

RNGT combines an observable trust-based redemption claim with an unknown future transaction. Upside depends on finding a mispriced business, negotiating disciplined terms, limiting redemptions, and securing financing. Time, competition, incentives, and capital constraints can instead produce no deal or a weak one.

Which KPIs should researchers monitor next?

Regulation adds another constraint: current SPAC rules emphasize conflicts, dilution, projections, and target-company responsibility. Trust assets may also shift from government securities or money-market funds into cash to reduce Investment Company Act exposure, which could lower interest income. Monitor the official company website and SEC filing page for updates.

What is the key takeaway for valuation and research?

A conventional discounted cash flow model is not yet the right primary tool for RNGT because there is no operating business, revenue forecast, margin structure, or target capital plan to discount. Before a deal announcement, analysis centers on trust value, time to the completion deadline, short-term interest income, outside-trust liquidity, redemption rights, sponsor incentives, and the market value of warrant optionality. The $234.164 million trust balance and approximately $10.18 per-share redemption value at March 31, 2026 provide a factual anchor, but they do not determine the value of the future combined company.

After a transaction is announced, researchers should build a pro forma value bridge covering target operating value, post-redemption cash, new debt or PIPE capital, fees, deferred underwriting, and all dilutive securities. A DCF should use the target’s growth, margins, taxes, capital spending, working capital, and terminal assumptions—not RNGT’s pre-deal interest. Low, medium, and high redemption cases can produce sharply different leverage and per-share outcomes.